IL-17A enhances IL-13 activity by enhancing IL-13–induced signal transducer and activator of transcription 6 activation

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 2, 2017, Pages 462-471.e14

  Hall, Sara L ^a   Baker, Theresa ^a   Lajoie, Stephane ^b   Richgels, Phoebe K ^a   Yang, Yanfen ^a   McAlees, Jaclyn W ^a   van Lier, Adelaide ^a   Wills Karp, Marsha ^b   Sivaprasad, Umasundari ^a   Acciani, Thomas H ^a   LeCras, Timothy D ^a   Myers, Jocelyn Biagini ^a   Kovacic, Melinda Butsch ^a   Lewkowich, Ian P ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Asthma; cytokines; IL 13; IL 17A; signal transducer and activator of transcription 6; signal transduction

Indexed keywords

ALOX15 PROTEIN; ARG1 PROTEIN; C3 PROTEIN; CA2 PROTEIN; CALGRANULIN A; CALGRANULIN B; CEBPB PROTEIN; CEBPD PROTEIN; CHLORIDE CHANNEL CALCIUM ACTIVATED 3 PROTEIN; CSF2 PROTEIN; CYCLOHEXIMIDE; DACTINOMYCIN; DIMETHYL SULFOXIDE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 17; INTERLEUKIN 4 RECEPTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN; SERPINB4 PROTEIN; STAT6 PROTEIN; TREFOIL FACTOR 2; UNCLASSIFIED DRUG; CYTOKINE; IL17R PROTEIN, MOUSE; INTERLEUKIN 17 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL HYPERPLASIA; COCULTURE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; FIBROBLAST CULTURE; GENE EXPRESSION; GOBLET CELL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LUNG HOMOGENATE; MOUSE; MUCUS SECRETION; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; WESTERN BLOTTING; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMICALLY INDUCED; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PNEUMONIA; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; ASTHMA; CELL LINE; CYTOKINES; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PNEUMONIA; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS;

EID: 85002515895     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.04.037     Document Type: Article

References (67)

1. 1 Grunig, G., Warnock, M., Wakil, A.E., Venkayya, R., Brombacher, F., Rennick, D.M., et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282 (1998), 2261–2263.
2. 2 Walter, D.M., McIntire, J.J., Berry, G., McKenzie, A.N., Donaldson, D.D., DeKruyff, R.H., et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 167 (2001), 4668–4675.
3. 3 Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., et al. Interleukin-13: central mediator of allergic asthma. Science 282 (1998), 2258–2261.
4. 4 Zhu, Z., Homer, R.J., Wang, Z., Chen, Q., Geba, G.P., Wang, J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103 (1999), 779–788.
5. 5 Kuperman, D.A., Huang, X., Koth, L.L., Chang, G.H., Dolganov, G.M., Zhu, Z., et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8 (2002), 885–889.
6. 6 Perkins, C., Yanase, N., Smulian, G., Gildea, L., Orekov, T., Potter, C., et al. Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice. J Exp Med 208 (2011), 853–867.
7. 7 Lajoie, S., Lewkowich, I.P., Suzuki, Y., Clark, J.R., Sproles, A.A., Dienger, K., et al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 11 (2010), 928–935.
8. 8 Wakashin, H., Hirose, K., Maezawa, Y., Kagami, S., Suto, A., Watanabe, N., et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 178 (2008), 1023–1032.
9. 9 Kudo, M., Melton, A.C., Chen, C., Engler, M.B., Huang, K.E., Ren, X., et al. IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat Med 18 (2012), 547–554.
10. 10 Al-Ramli, W., Prefontaine, D., Chouiali, F., Martin, J.G., Olivenstein, R., Lemiere, C., et al. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 123 (2009), 1185–1187.
11. 11 Barczyk, A., Pierzchala, W., Sozanska, E., Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 97 (2003), 726–733.
12. 12 Bullens, D.M., Truyen, E., Coteur, L., Dilissen, E., Hellings, P.W., Dupont, L.J., et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?. Respir Res, 7, 2006, 135.
13. 13 McKinley, L., Alcorn, J.F., Peterson, A., Dupont, R.B., Kapadia, S., Logar, A., et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 181 (2008), 4089–4097.
14. 14 Molet, S., Hamid, Q., Davoine, F., Nutku, E., Taha, R., Page, N., et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108 (2001), 430–438.
15. 15 Cosmi, L., Maggi, L., Santarlasci, V., Capone, M., Cardilicchia, E., Frosali, F., et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 125 (2010), 222–230 e1-4.
16. 16 Irvin, C., Zafar, I., Good, J., Rollins, D., Christianson, C., Gorska, M.M., et al. Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. J Allergy Clin Immunol 134 (2014), 1175–1186.e7.
17. 17 Wang, Y.H., Voo, K.S., Liu, B., Chen, C.Y., Uygungil, B., Spoede, W., et al. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 207 (2010), 2479–2491.
18. 18 Kinyanjui, M.W., Shan, J., Nakada, E.M., Qureshi, S.T., Fixman, E.D., Dose-dependent effects of IL-17 on IL-13-induced airway inflammatory responses and airway hyperresponsiveness. J Immunol 190 (2013), 3859–3868.
19. 19 Murdoch, J.R., Lloyd, C.M., Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing γδ T cells. Am J Respir Crit Care Med 182 (2010), 464–476.
20. 20 Guajardo, J.R., Schleifer, K.W., Daines, M.O., Ruddy, R.M., Aronow, B.J., Wills-Karp, M., et al. Altered gene expression profiles in nasal respiratory epithelium reflect stable versus acute childhood asthma. J Allergy Clin Immunol 115 (2005), 243–251.
21. 21 Chiaramonte, M.G., Mentink-Kane, M., Jacobson, B.A., Cheever, A.W., Whitters, M.J., Goad, M.E., et al. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 197 (2003), 687–701.
22. 22 Daines, M.O., Hershey, G.K., A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma. J Biol Chem 277 (2002), 10387–10393.
23. 23 Wood, N., Whitters, M.J., Jacobson, B.A., Witek, J., Sypek, J.P., Kasaian, M., et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med 197 (2003), 703–709.
24. 24 Chen, W., Sivaprasad, U., Gibson, A.M., Ericksen, M.B., Cunningham, C.M., Bass, S.A., et al. IL-13 receptor alpha2 contributes to development of experimental allergic asthma. J Allergy Clin Immunol 132 (2013), 951–958 e1-6.
25. 25 Hartupee, J., Liu, C., Novotny, M., Li, X., Hamilton, T., IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 179 (2007), 4135–4141.
26. 26 Hartupee, J., Liu, C., Novotny, M., Sun, D., Li, X., Hamilton, T.A., IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6. J Immunol 182 (2009), 1660–1666.
27. 27 Henness, S., Johnson, C.K., Ge, Q., Armour, C.L., Hughes, J.M., Ammit, A.J., IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability. J Allergy Clin Immunol 114 (2004), 958–964.
28. 28 Heller, N.M., Qi, X., Junttila, I.S., Shirey, K.A., Vogel, S.N., Paul, W.E., et al. Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. Sci Signal, 1, 2008, ra17.
29. 29 Umeshita-Suyama, R., Sugimoto, R., Akaiwa, M., Arima, K., Yu, B., Wada, M., et al. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation. Int Immunol 12 (2000), 1499–1509.
30. 30 Wery-Zennaro, S., Letourneur, M., David, M., Bertoglio, J., Pierre, J., Binding of IL-4 to the IL-13Ralpha(1)/IL-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation. FEBS Lett 464 (1999), 91–96.
31. 31 Sozzani, P., Hasan, L., Seguelas, M.H., Caput, D., Ferrara, P., Pipy, B., et al. IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production. Biochem Biophys Res Commun 244 (1998), 665–670.
32. 32 Chen, H.C., Reich, N.C., Live cell imaging reveals continuous STAT6 nuclear trafficking. J Immunol 185 (2010), 64–70.
33. 33 Moon, M.R., Parikh, A.A., Pritts, T.A., Fischer, J.E., Cottongim, S., Szabo, C., et al. Complement component C3 production in IL-1beta-stimulated human intestinal epithelial cells is blocked by NF-kappaB inhibitors and by transfection with ser 32/36 mutant IkappaBalpha. J Surg Res 82 (1999), 48–55.
34. 34 Juan, T.S., Wilson, D.R., Wilde, M.D., Darlington, G.J., Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3. Proc Natl Acad Sci U S A 90 (1993), 2584–2588.
35. 35 Gray, M.J., Poljakovic, M., Kepka-Lenhart, D., Morris, S.M. Jr., Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene 353 (2005), 98–106.
36. 36 David, M.D., Bertoglio, J., Pierre, J., Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression. Oncogene 22 (2003), 3386–3394.
37. 37 Dickensheets, H.L., Venkataraman, C., Schindler, U., Donnelly, R.P., Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci U S A 96 (1999), 10800–10805.
38. 38 Hebenstreit, D., Luft, P., Schmiedlechner, A., Duschl, A., Horejs-Hoeck, J., SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells. Mol Immunol 42 (2005), 295–303.
39. 39 Hebenstreit, D., Luft, P., Schmiedlechner, A., Regl, G., Frischauf, A.M., Aberger, F., et al. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J Immunol 171 (2003), 5901–5907.
40. 40 Woetmann, A., Brockdorff, J., Lovato, P., Nielsen, M., Leick, V., Rieneck, K., et al. Protein phosphatase 2A (PP2A) regulates interleukin-4-mediated STAT6 signaling. J Biol Chem 278 (2003), 2787–2791.
41. 41 Lu, X., Malumbres, R., Shields, B., Jiang, X., Sarosiek, K.A., Natkunam, Y., et al. PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. Blood 112 (2008), 4098–4108.
42. 42 Haque, S.J., Harbor, P., Tabrizi, M., Yi, T., Williams, B.R., Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J Biol Chem 273 (1998), 33893–33896.
43. 43 Tao, B., Jin, W., Xu, J., Liang, Z., Yao, J., Zhang, Y., et al. Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis. J Immunol 193 (2014), 2801–2811.
44. 44 Wei, Q., Sha, Y., Bhattacharya, A., Abdel Fattah, E., Bonilla, D., Jyothula, S.S., et al. Regulation of IL-4 receptor signaling by STUB1 in lung inflammation. Am J Respir Crit Care Med 189 (2014), 16–29.
45. 45 Sahoo, A., Alekseev, A., Obertas, L., Nurieva, R., Grail controls Th2 cell development by targeting STAT6 for degradation. Nat Commun, 5, 2014, 4732.
46. 46 Qiao, G., Ying, H., Zhao, Y., Liang, Y., Guo, H., Shen, H., et al. E3 ubiquitin ligase Cbl-b suppresses proallergic T cell development and allergic airway inflammation. Cell Rep 6 (2014), 709–723.
47. 47 Huang, F., Wachi, S., Thai, P., Loukoianov, A., Tan, K.H., Forteza, R.M., et al. Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. J Allergy Clin Immunol 121 (2008), 1415–1421 e1-3.
48. 48 Lewkowich, I.P., Lajoie, S., Clark, J.R., Herman, N.S., Sproles, A.A., Wills-Karp, M., Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice. PLoS One, 3, 2008, e3879.
49. 49 Wilson, R.H., Whitehead, G.S., Nakano, H., Free, M.E., Kolls, J.K., Cook, D.N., Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med 180 (2009), 720–730.
50. 50 Newcomb, D.C., Boswell, M.G., Reiss, S., Zhou, W., Goleniewska, K., Toki, S., et al. IL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation. Thorax 68 (2013), 717–723.
51. 51 Besnard, A.G., Sabat, R., Dumoutier, L., Renauld, J.C., Willart, M., Lambrecht, B., et al. Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am J Respir Crit Care Med 183 (2011), 1153–1163.
52. 52 Wands, J.M., Roark, C.L., Aydintug, M.K., Jin, N., Hahn, Y.S., Cook, L., et al. Distribution and leukocyte contacts of gammadelta T cells in the lung. J Leukoc Biol 78 (2005), 1086–1096.
53. 53 Allen, H.B., Vaze, N.D., Choi, C., Hailu, T., Tulbert, B.H., Cusack, C.A., et al. The presence and impact of biofilm-producing staphylococci in atopic dermatitis. JAMA Dermatol 150 (2014), 260–265.
54. 54 Clausen, M.L., Slotved, H.C., Krogfelt, K.A., Andersen, P.S., Agner, T., In vivo expression of antimicrobial peptides in atopic dermatitis. Exp Dermatol 25 (2016), 3–9.
55. 55 Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., et al. Disordered microbial communities in asthmatic airways. PLoS One, 5, 2010, e8578.
56. 56 Huang, Y.J., Boushey, H.A., The microbiome in asthma. J Allergy Clin Immunol 135 (2015), 25–30.
57. 57 Choy, D.F., Hart, K.M., Borthwick, L.A., Shikotra, A., Nagarkar, D.R., Siddiqui, S., et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med, 7, 2015, 301ra129.
58. 58 Hinks, T.S., Zhou, X., Staples, K.J., Dimitrov, B.D., Manta, A., Petrossian, T., et al. Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms. J Allergy Clin Immunol 136 (2015), 323–333.
59. 59 Persson, H., Kwon, A.T., Ramilowski, J.A., Silberberg, G., Soderhall, C., Orsmark-Pietras, C., et al. Transcriptome analysis of controlled and therapy-resistant childhood asthma reveals distinct gene expression profiles. J Allergy Clin Immunol 136 (2015), 638–648.
60. 60 Woodruff, P.G., Modrek, B., Choy, D.F., Jia, G., Abbas, A.R., Ellwanger, A., et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180 (2009), 388–395.
61. 61 Wu, W., Bleecker, E., Moore, W., Busse, W.W., Castro, M., Chung, K.F., et al. Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. J Allergy Clin Immunol 133 (2014), 1280–1288.
62. 62 Newcomb, D.C., Boswell, M.G., Huckabee, M.M., Goleniewska, K., Dulek, D.E., Reiss, S., et al. IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. J Immunol 188 (2012), 1027–1035.
63. 63 Newcomb, D.C., Boswell, M.G., Zhou, W., Huckabee, M.M., Goleniewska, K., Sevin, C.M., et al. Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production. J Allergy Clin Immunol 127 (2011), 1006–1013 e1-4.
64. 64 Newcomb, D.C., Zhou, W., Moore, M.L., Goleniewska, K., Hershey, G.K., Kolls, J.K., et al. A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production. J Immunol 182 (2009), 5317–5321.
65. 65 Wilson, M.S., Ramalingam, T.R., Rivollier, A., Shenderov, K., Mentink-Kane, M.M., Madala, S.K., et al. Colitis and intestinal inflammation in IL10-/- mice results from IL-13Ralpha2-mediated attenuation of IL-13 activity. Gastroenterology 140 (2011), 254–264.
66. 66 Busse, W.W., Holgate, S., Kerwin, E., Chon, Y., Feng, J., Lin, J., et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med 188 (2013), 1294–1302.
67. Lewkowich, I.P., Lajoie, S., Clark, J.R., Herman, N.S., Sproles, A.A., Wills-Karp, M., Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice. PLoS One, 3, 2008, e3879.